BELKYRA® FAT DISSOLVING INJECTIONS
Epsom Skin Clinics has been approached to be one of a handful of clinics nationwide to launch BELKYRA® (also known as Kybella) to the UK market, due to our many years of experience in the field of anti-aging injections.
The treatment is designed to treat ‘submental fullness’, which involves dissolving excess fat beneath your chin (double chin). The long and anticipated launch of BELKYRA® now means that there is a new and remarkably effective choice for treating this normally difficult area.
Compared to the higher price and risks attached to surgical options, treatment with these fat-dissolving injections offer clear advantages & benefits for you.
What is BELKYRA®?
It is a non-invasive treatment for double chin fullness which has shown meaningful results in over 90% of patients.
It is ideal if you have a mild to moderate amount of fat beneath your chin, enabling our doctors to target this area very precisely, breaking down the fatty deposits. However, this is not an substitution to healthy diet and exercise where there is a more generalised weight or obesity issue.
Where has BELKYRA® come from?
Whilst BELKYRA® is new to the UK market, it has been a proven & popular treatment for a number of years in the USA, where it is known as Kybella. It has now been passed by the MHRA (Medicines and Healthcare products Regulatory Agency) for release in the UK.
How Does BELKYRA® Work?
BELKYRA® (Kybella) is an injectable product which is based on Deoxycholic acid. Deoxycholic acid is produced naturally in your body, where normally works to help the body to absorb fat.
When injected into fatty tissues, the agent physically destroys your fat cells, breaking down deposits of fat leaving you with a smoother and more lean profile.
What to Expect from BELKYRA®?
BELKYRA® is administered as an injection into the fat tissue in your chin area (submental). Treatment can involve up to 50 injections in order to treat the whole area evenly and comprehensively. For best results, our doctors may recommend a course of treatments for you with up to 6 sessions 3-4 weeks apart.
Manufacturers Kythera Biopharmaceuticals Inc said over 90% of those who tried the drug maintained a meaningful reduction of fat after two years, based on trials across Europe and the United States.
Is BELKYRA® safe?
The U.S. Food and Drug Administration (FDA) approved Kybella as a treatment for adults with moderate-to-severe fat below the chin, known as submental fat.
BELKYRA® (UK brand name) has now been approved by the MHRA for use in the UK.